Document:

Exhibit 10.9.5
​
FIFTH AMENDMENT TO LEASE
​
This is a Fifth Amendment to Lease dated as of November 30, 020 by and between SNH Medical Office Properties Trust, a Maryland real estate investment trust (“Landlord”), and Axogen Corporation, a Delaware corporation (“Tenant”).
​
WHEREAS, Wigshaw, LLC (“Original Landlord”) and Tenant entered into that certain Lease dated February 6, 2007 (the “Original Lease”), for certain premises in the building known as Progress One and located at 13859 Progress Boulevard, Alachua, Florida; and
​
WHEREAS, Landlord succeeded to the interest of Original Landlord under the Original Lease and with Tenant entered into that certain First Amendment to Lease dated March 14, 2012, that certain Second Amendment to Lease dated February 25, 2013, and that certain Third Amendment to Lease (the “Third Amendment”) dated November 12, 2013 (the Original Lease as so amended being hereinafter referred to as the “13859 Lease”); and
​
WHEREAS, pursuant to the Third Amendment, the premises demised by the 13859 Lease were relocated to approximately 11,761 rentable square feet (the “Relocated Premises”) in the building known as Progress Two and located at 13631 Progress Boulevard, Alachua, Florida, as more particularly described in the Third Amendment; and
​
WHEREAS, Landlord and Tenant entered into a Fourth Amendment to Lease (the “Fourth Amendment”) dated as of March 16, 2016 expanding the premises demised to Tenant at 13631 Progress Boulevard (the 13859 Lease as so amended being the “Lease”); and
​
WHEREAS, Landlord and Tenant have agreed to amend the Lease to cause the terms attributable to all of the premises demised by the Lease to be co-terminous and to expire on October 31, 2021, subject to and upon the terms and conditions hereinafter provided; and
​
NOW, THEREFORE, in consideration of the foregoing and for other consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant agree that the Lease is hereby amended as follows:
​
1.Capitalized terms used and not otherwise defined herein shall have the meanings ascribed to such terms in the Lease.
​
2.The definition of “Term” set forth in Section 1.1(l) of the Original Lease is hereby amended to reflect that the Term shall expire on October 31, 2021, which shall be the Expiration Date. Section 13 of the Fourth Amendment shall be null and void.
​
3.“Annual Gross Rent” for the period from November 1, 2020 through October 31, 2021 shall be $370,701.81per annum.
​
4.The provisions of Sections 10 and 11 of the Fourth Amendment are hereby deleted and the following is inserted in their place:
​
So long as the Lease is still in full force and effect, and subject to the Conditions (as hereinafter defined), which Landlord may waive, in its discretion, at any time, but only by notice
​
​

​
-2-
​
to Tenant, Tenant shall have the right to extend the Term for one (1) additional period of five (5) years (the “Extended Term”) commencing on November 1, 2021 and expiring on October 31, 2026. All of the terms, covenants and provisions of the Lease in effect immediately prior to the commencement of the Extended Term shall apply to such Extended Term except that (i) the Annual Gross Rent for each year of such Extended Term shall be equal to one hundred and three percent (103%) of the Annual Gross Rent in effect for each immediately preceding year; (ii) Tenant shall have no further right to extend the Term beyond the Extended Term hereinabove provided and (iii) the Expiration Date shall be amended to be October 31, 2026. If Tenant shall elect to exercise the aforesaid option, it shall do so by giving Landlord notice (an “Election Notice”) of such election not later than January 31, 2021. If Tenant fails to give such Election Notice to Landlord timely, the Term shall automatically terminate no later than October 31, 2021, and Tenant shall have no further option to extend the Term, it being agreed that time is of the essence with respect to the giving of the Election Notice. If Tenant shall extend the Term pursuant to the provisions of this paragraph, such extension shall (subject to satisfaction of the Conditions, unless waived by Landlord) be automatically effected without the execution of any additional documents. The “Conditions” are that, as of the date of the Election Notice, there shall exist no event of default by Tenant and Axogen Corporation shall actually occupy the then current entire Leased Premises.
​
		5.
	As amended hereby, the Lease is hereby ratified and confirmed.

​
IN WITNESS WHEREOF, the parties hereunto have executed this Fifth Amendment as of the date first written above.
​
	​

	​

	​

	​

	​
	LANDLORD:
	​
	​

	​
	​
	​
	​

	​
	SNH Medical Office Properties Trust By:   The RMR Group LLC, its agent

	​
	​

	​
	By:
	/s/ Jennifer F. Francis
	​

	​
	​
	   Executive Vice President
	​

	​
	​
	​
	​

	​
	​
	​
	​

	​
	TENANT:
	​

	​
	​
	​
	​

	​
	Axogen Corporation
	​

	​
	​
	​
	​

	​
	By:
	/s/ Peter J. Mariani
	​

	​
	​
	   Chief Financial Officer
	​

​Document

Exhibit 10.1

DOCUSIGN, INC.
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
(Amended & Restated as of May 29, 2020)

Each member of the Board of Directors (the “Board”) of DocuSign, Inc. (the “Company”) who is a non-employee director of the Company (each such member, a “Non-Employee Director”) will receive the compensation described in this Amended and Restated Non-Employee Director Compensation Policy (the “Director Compensation Policy”) for his or her Board service. 

The Director Compensation Policy may be amended or terminated at any time in the sole discretion of the Board. 

A Non-Employee Director may decline all or any portion of his or her compensation by giving notice to the Company prior to the date cash is to be paid or equity awards are to be granted, as the case may be.1 

Annual Cash Compensation

Each Non-Employee Director will receive the cash compensation set forth below for service on the Board.  The annual cash compensation amounts will be payable in equal quarterly installments, in arrears following the end of each fiscal quarter in which the service occurred, pro-rated for any partial months of service.  All annual cash fees are vested upon payment.

1.Annual Board Service Retainer:
a.All Eligible Directors: $33,500
b.Chairman or Lead Independent Director: $77,500 (in lieu of above) 

2.Annual Committee Member Service Retainer:
a.Member of the Audit Committee: $10,000
b.Member of the Compensation Committee: $6,600
c.Member of the Nominating and Corporate Governance Committee: $4,000

3.Annual Committee Chair Service Retainer (in lieu of Committee Member Service Retainer):
a.Chairman of the Audit Committee: $20,000
b.Chairman of the Compensation Committee: $13,500
c.Chairman of the Nominating and Corporate Governance Committee: $7,800

Equity Compensation

Equity awards will be granted under the Company’s 2018 Equity Incentive Plan or any successor equity incentive plan (the “Plan”).  All stock options granted under this policy will be Nonstatutory Stock Options (as defined in the Plan), with a term of ten years from the date of grant and an exercise price per share equal to 100% of the Fair Market Value (as defined in the Plan) of the underlying common stock of the Company on the date of grant.

1 This is included to allow a director who works for a fund to forfeit payments and avoid being deemed to have “constructively received” the payment for tax purposes (and be required to recognize the value as income for tax purposes) in a scenario where the director is obligated under a contractual obligation with the fund to disgorge such payments to the fund.

1.Automatic Equity Grants:

a.Initial Grant for New Directors. Without any further action of the Board, each person who is elected or appointed for the first time to be a Non-Employee Director will automatically, upon the date of his or her initial election or appointment to be a Non-Employee Director, be granted a Restricted Stock Unit for a number of shares of common stock having a value of $400,000 (the “Initial Grant”).  Each Initial Grant will vest in a series of 12 equal quarterly installments over the 3-year period measured from the date of grant.  

b.Annual Grant. Without any further action of the Board, commencing in fiscal 2020 and each fiscal year thereafter at the close of business on the date of each Annual Meeting, each person who is then a Non-Employee Director will automatically be granted a Restricted Stock Unit to purchase a number of shares of common stock having a value of $200,000 (the “Annual Grant”). Notwithstanding the foregoing, a director who is elected or appointed for the first time less than nine (9) months prior to the date such grants are made to executive officers or the date of such Annual Meeting shall not be eligible to receive such Annual Grant.  Each Annual Grant (including, for the avoidance of doubt, the Annual Grants awarded in fiscal 2020) will vest in a series of four successive equal quarterly installments over the one-year period measured from the date of grant; provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Annual Meeting following the date of grant and (ii) the date that is one year following the date of grant of the Annual Grant, in each case, so long as the Non-Employee Director remains in Continuous Service (as defined below) through such date.  If a Non-Employee Director’s Continuous Service ends on the date of vesting, then the vesting shall be deemed to have occurred.

2.Vesting; Change of Control.  All vesting is subject to the Non-Employee Director’s “Continuous Service” (as defined in the Plan) on each applicable vesting date.  Notwithstanding the foregoing vesting schedules, for each Non-Employee Director who remains in Continuous Service with the Company until immediately prior to the closing of a “Change of Control” (as defined in the Plan), the shares subject to his or her then-outstanding equity awards that were granted pursuant to this policy will become fully vested immediately prior to the closing of such Change of Control.  

3.Calculation Value of a Restricted Stock Unit Award. The value of a restricted stock unit award to be granted under this policy will be determined based on the Fair Market Value per share on the grant date (as defined in the Plan).

4.Remaining Terms. The remaining terms and conditions of each Restricted Stock Unit, including transferability, will be as set forth in the Company’s standard Restricted Stock Agreement, in the form adopted from time to time by the Board or Compensation Committee.

Expenses

The Company will reimburse Non-Employee Director for ordinary, necessary and reasonable out-of-pocket travel expenses to cover in-person attendance at and participation in Board and committee meetings; provided, that the Non-Employee Director timely submit to the Company appropriate documentation substantiating such expenses in accordance with the Company’s travel and expense policy, as in effect from time to time.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]